Keyword: pancreatic cancer
News
12.01.2017
- French drugmaker Ipsen has signed a definitive agreement to buy the global oncology assets of US-based Merrimack Pharmaceuticals in a deal worth potentially more than $1 billion...
News
24.02.2016
- Austrian biotech firm OncoQR ML has cleared an important hurdle toward producing a vaccine against pancreatic cancer. In a preclinical trial of what it termed “a highly relevant...
News
29.10.2015
- The US Food and Drug Administration (FDA) has approved, with reservations, the new pancreatic cancer drug Onivyde manufactured by US drugmaker Merrimack for use in combination with...
News
21.04.2015
- ChemoCentryx, Inc, a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, has begun enrolling patients with non-resectable...
